HIV Malignancy Specimens for Research at No Charge
In this opinion piece featured in JAMA, Lawrence Corey, Russell Corbett-Detig, Chris Beyrer write about the exceedingly harmful effects that SARS-CoV-2 variants and HIV has had on the other. The …
Use of stem cells for research has not be conducted without its share of controversy. New research using a new transplant method involving umbilical cord blood, presented at this year’s …
Our recent experiences with the coronavirus pandemic have demonstrated that new mutations in viral genetic sequences can have significant impacts on the virus’s transmissibility and the degrees of illness it …
How do HIV/AIDS & cancer research continue to converge? Read more about the early results from a novel study which shows that pembrolizumab, a cancer drug, can flush HIV from …
As 2021 comes to a close, we celebrate some important work published by our colleagues (Ambinder, et al) who dedicate their careers to improving diagnosis, treatment and outcomes for people …
The ACSR celebrates Dr. John Mellors, et al, for their recent publication in Science and their groundbreaking research showing the important role of HIV provirus integration in the development of T-Cell Lymphoma …
The early months of the SARS-CoV-2 pandemic forced many laboratories and biobanks, including the ACSR, to develop contingency plans for biobank operations. Fear of the unknown, uncertainty and unpredictability, and …
The ACSR is proud to share the latest EBV/DLBCL research from the ACSR’s own Lisa Rimsza, Alanna Maguire, and inaugural YIPA Awardee, Joo Song! EBV-positive HIV-associated diffuse large B cell …
Everyday, but most especially today, World Cancer Day, the ACSR stands up to cancer. Together, all of our actions matter and the ACSR recommits to supporting our cancer warriors in …
Using ACSR Specimens, Colm Keane et al. give us the largest in-depth description of the biology of Primary Central Nervous Lymphoma occurring in patients with AIDS. This disease demonstrates a …
